Artisan Partners’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-612,438
| Closed | -$8.33M | – | 344 |
|
|
2025
Q1 | $8.33M | Sell |
612,438
-442,085
| -42% | -$6.01M | 0.01% | 308 |
|
|
2024
Q4 | $21.5M | Sell |
1,054,523
-36,495
| -3% | -$744K | 0.03% | 286 |
|
|
2024
Q3 | $31.8M | Sell |
1,091,018
-50,499
| -4% | -$1.47M | 0.05% | 258 |
|
|
2024
Q2 | $26.5M | Buy |
1,141,517
+775,685
| +212% | +$18M | 0.04% | 260 |
|
|
2024
Q1 | $7.51M | Sell |
365,832
-18,110
| -5% | -$372K | 0.01% | 300 |
|
|
2023
Q4 | $8.24M | Sell |
383,942
-22,680
| -6% | -$487K | 0.01% | 283 |
|
|
2023
Q3 | $8.39M | Sell |
406,622
-10,161
| -2% | -$210K | 0.01% | 280 |
|
|
2023
Q2 | $12.3M | Sell |
416,783
-6,882
| -2% | -$203K | 0.02% | 265 |
|
|
2023
Q1 | $9.76M | Sell |
423,665
-12,008
| -3% | -$277K | 0.02% | 274 |
|
|
2022
Q4 | $12.1M | Sell |
435,673
-7,428
| -2% | -$207K | 0.02% | 270 |
|
|
2022
Q3 | $13.6M | Sell |
443,101
-7,588
| -2% | -$233K | 0.02% | 271 |
|
|
2022
Q2 | $13.3M | Sell |
450,689
-73,442
| -14% | -$2.16M | 0.02% | 268 |
|
|
2022
Q1 | $16.9M | Buy |
524,131
+2,723
| +0.5% | +$87.6K | 0.02% | 288 |
|
|
2021
Q4 | $23.3M | Sell |
521,408
-29,579
| -5% | -$1.32M | 0.03% | 289 |
|
|
2021
Q3 | $27.8M | Sell |
550,987
-15,858
| -3% | -$800K | 0.03% | 279 |
|
|
2021
Q2 | $44.5M | Buy |
566,845
+979
| +0.2% | +$76.8K | 0.05% | 247 |
|
|
2021
Q1 | $32.3M | Buy |
565,866
+142,513
| +34% | +$8.14M | 0.04% | 271 |
|
|
2020
Q4 | $35.5M | Buy |
+423,353
| New | +$35.5M | 0.04% | 260 |
|